How Long Can a Person Live with Hepatitis B Cirrhosis?

The life expectancy of individuals with hepatitis B-related cirrhosis largely depends on the stage and severity of the disease. Below is a detailed breakdown based on disease progression:

Compensated Cirrhosis: In this early stage, patients typically do not experience complications such as portal hypertension. With consistent and effective treatment to suppress the hepatitis B virus (HBV), liver function can be preserved. By preventing further liver fibrosis and deterioration, patients may live for many years—often between 10 to 30 years—with a relatively good quality of life.

Decompensated Cirrhosis: This stage indicates more severe liver damage and is marked by the development of serious complications. These may include hepatic encephalopathy, hepatorenal syndrome, and life-threatening events such as variceal bleeding from esophageal or gastric veins. Each complication can significantly increase the risk of mortality. The survival rate at this stage varies depending on the type, frequency, and severity of complications. The Child-Pugh classification is commonly used to assess prognosis, with Class A patients having the best outlook (median survival of 15–20 years) and Class C patients facing the most critical condition and shortest survival time (often less than 1–2 years).

Improving Prognosis Through Management: For individuals living with hepatitis B cirrhosis, the key to extending life expectancy lies in effective viral suppression, regular monitoring of liver function, and early intervention to prevent or manage complications. Antiviral therapy plays a central role in slowing disease progression and reducing the risk of liver failure and hepatocellular carcinoma.

Conclusion: While hepatitis B cirrhosis is a serious condition, especially in its decompensated form, timely medical care and lifestyle adjustments can significantly impact survival and quality of life. Regular follow-ups with a hepatologist and adherence to treatment are essential for optimal outcomes.